Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD44: a stemness driver, regulator, and marker—all in one?

4 Oct 2024

Abstract excerpt

Although the concept of cancer stem cells is still controversial, previous studies have shown that blood cancers, as well as specific types of solid cancers such as colorectal cancer, rely on stem cells during the onset of tumor growth and further tumor development. Moreover, resistance to therapeutic treatment in leukemias such as acute myeloid leukemia and in colorectal cancer can be attributed to a small...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Electrospun Nanofibers in Biomedical Applications
Share to Tissue Engineering and Regenerative Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39364735
DOI: 10.1093/stmcls/sxae060

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD44: a stemness driver, regulator, and marker—all in one?PMID 39364735Read ↗

Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial–Mesenchymal Transition, and MetastasisSemantic proximity Read ↗

The Cancer Stem Cell Marker CD44 Play Key Roles in Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis in Several Human CancersSemantic proximity Read ↗

Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic TargetSemantic proximity Read ↗

CD133: A cancer stem cells marker, is used in colorectal cancersSemantic proximity Read ↗

New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulationSemantic proximity Read ↗

Cancer stem cells as new therapeutic target to prevent tumour progression and metastasisSemantic proximity Read ↗

Stemness-related markers in cancerSemantic proximity Read ↗

Cancer stem cells: The important role of CD markers, Signaling pathways, and MicroRNAsSemantic proximity Read ↗

CD44 on cancer stem cell is a potential immunological and prognostic pan-cancer biomarkerSemantic proximity Read ↗

Stem cells and cancer: an intimate relationshipSemantic proximity Read ↗

Cancer Stem Cells: The Emerging Challenge of Drug TargetingSemantic proximity Read ↗

CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challengesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.